Abbott Laboratories (ABT) Financial Statements
Abbott Laboratories financial statements at a glance
Abbott Laboratories reported revenue of $44.33 billion for fiscal year 2025 (ended December 31, 2025), up 5.7% from fiscal year 2024. Net income was $6.52 billion, a net margin of 14.7%, and diluted earnings per share were $3.72.
At the end of fiscal year 2025 it had total assets of $86.71 billion, total liabilities of $33.94 billion and shareholders' equity of $52.13 billion, with cash and short-term investments of $8.94 billion and total debt of $13.86 billion.
Its operations brought in $9.57 billion of cash; capital spending was $2.17 billion, leaving free cash flow of $7.40 billion.
The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.
Figures from company filings, in USD; latest fiscal year ended December 31, 2025.
Abbott Laboratories
Income Statement
Annual • USD
Abbott Laboratories key figures by fiscal year
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $44.3B | $42.0B | $40.1B | $43.7B | $43.1B |
| Gross profit | $25.0B | $23.2B | $22.1B | $24.5B | $24.5B |
| Operating income | $8.1B | $6.8B | $6.5B | $8.4B | $8.4B |
| Net income | $6.5B | $13.4B | $5.7B | $6.9B | $7.1B |
| Diluted EPS | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 |
| Total assets | $86.7B | $81.4B | $73.2B | $74.4B | $75.2B |
| Total liabilities | $33.9B | $33.5B | $34.4B | $37.5B | $39.2B |
| Shareholders' equity | $52.1B | $47.7B | $38.6B | $36.7B | $35.8B |
| Cash and short-term investments | $8.9B | $8.0B | $7.3B | $10.2B | $10.2B |
| Total debt | $13.9B | $15.0B | $15.6B | $17.7B | $19.0B |
| Operating cash flow | $9.6B | $8.6B | $7.3B | $9.6B | $10.5B |
| Capital spending | $2.2B | $2.2B | $2.2B | $1.8B | $1.9B |
| Free cash flow | $7.4B | $6.4B | $5.1B | $7.8B | $8.6B |
In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2020.
Questions and answers
What was Abbott Laboratories's revenue in fiscal year 2025?
$44.33 billion, up 5.7% from $41.95 billion in fiscal year 2024.
How much profit does Abbott Laboratories make?
Abbott Laboratories reported net income of $6.52 billion for fiscal year 2025 (14.7% of revenue); operating income was $8.05 billion.
How much cash and debt does Abbott Laboratories have?
At the end of fiscal year 2025: cash and short-term investments of $8.94 billion and total debt of $13.86 billion.
What is Abbott Laboratories's free cash flow?
$7.40 billion in fiscal year 2025 (operating cash flow of $9.57 billion minus capital spending of $2.17 billion).
